Terms ending in 2038
Every in-force patent on Shire LLC's record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,896,749 | Drug Monitoring Tool In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 11,783,931 | Drug Monitoring Tool In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 11,806,513 | Small Unit Dosage Plunger Rod Stops In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 10,835,583 | Messenger RNA Therapy for the Treatment of Ornithine Transcarbamylase Deficiency In force · High confidence | Translate Bio, Inc. | In force | High confidence | |
| US D1,002,837 | Medicament Access Device In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 11,660,328 | GLP-2 Analogs and Peptibodies for Administration Before, During or After Surgery In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 11,969,703 | Antibody-Resin Coupling Apparatus and Methods In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Shire LLC.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.